Zobrazeno 1 - 10
of 866
pro vyhledávání: '"Glenn M, Chertow"'
Publikováno v:
BMC Primary Care, Vol 25, Iss 1, Pp 1-5 (2024)
Abstract Kidney disease and its comorbidities disproportionately affect older persons. Kidney disease modifying therapy is underutilized in older adults, as guidelines lack consensus on approaching diagnosis and treatment in older adults. This review
Externí odkaz:
https://doaj.org/article/7981a83843cb40c1956fff38834529f0
Autor:
Smeeta Sinha, Sagar U. Nigwekar, Vincent Brandenburg, Lisa J. Gould, Thomas E. Serena, Sharon M. Moe, George R. Aronoff, Dinesh K. Chatoth, Jeffrey L. Hymes, Kevin J. Carroll, Gabriela Alperovich, Laurence H. Keller, Joan Perelló, Alex Gold, Glenn M. Chertow
Publikováno v:
EClinicalMedicine, Vol 75, Iss , Pp 102784- (2024)
Summary: Background: In the CALCIPHYX trial, we investigated hexasodium fytate, an inhibitor of vascular calcification, for the treatment of calcific uraemic arteriolopathy (calciphylaxis), a rare condition characterised by painful, non-healing skin
Externí odkaz:
https://doaj.org/article/ed79d86af030474a941e83bc9d1bd82e
Publikováno v:
Glomerular Diseases, Vol 4, Iss 1, Pp 64-73 (2024)
Introduction: Toxic gain-of-function Apolipoprotein L1 (APOL1) variants contribute to the development of proteinuric nephropathies collectively referred to as APOL1-mediated kidney disease (AMKD). Despite standard-of-care treatments, patients with AM
Externí odkaz:
https://doaj.org/article/ac820546dd95449ba9f0f84a346c1604
Autor:
Anjay Rastogi, Ashté Collins, Ellie Kelepouris, Wayne Kotzker, John P. Middleton, Minesh Rajpal, Prabir Roy-Chaudhury, Glenn M. Chertow
Publikováno v:
Journal of Primary Care & Community Health, Vol 15 (2024)
Introduction: There remains an unmet need to reduce kidney and cardiovascular risk in patients with chronic kidney disease (CKD). This report is therefore intended to provide real-world clinical guidance to primary care providers on sodium-glucose co
Externí odkaz:
https://doaj.org/article/22441855f2764e51bfe695489d1f351f
Publikováno v:
Kidney Medicine, Vol 6, Iss 8, Pp 100851- (2024)
Originally developed for use in type 2 diabetes mellitus (T2DM), sodium–glucose co-transporter-2 (SGLT2) inhibitors demonstrated diverse cardiovascular- and kidney-protective effects in large outcome trials. Their subsequent approval as a treatment
Externí odkaz:
https://doaj.org/article/e4a5f473d4f8447c86f52c8b6ba447b9
Autor:
Trenton M. Haltom, Susie Q. Lew, Wolfgang C. Winkelmayer, Glenn M. Chertow, Allison Jaure, Kevin F. Erickson
Publikováno v:
Kidney Medicine, Vol 6, Iss 7, Pp 100848- (2024)
Rationale & Objective: In the wake of the coronavirus disease 2019 (COVID-19) pandemic, the United States federal government expanded originating telemedicine sites to include outpatient dialysis units. For the first time, nephrology practitioners ac
Externí odkaz:
https://doaj.org/article/4f14bbf48e8a4f0aa9b9a83669dd8409
Autor:
Glenn M. Chertow, Hiddo Lambers Heerspink, Patrick B. Mark, Jamie P. Dwyer, Michal Nowicki, David C. Wheeler, Ricardo Correa-Rotter, Peter Rossing, Robert D. Toto, Anna Maria Langkilde, Niels Jongs
Publikováno v:
Glomerular Diseases (2024)
Introduction Despite the provision of renin-angiotensin-aldosterone-system inhibitors and immunosuppressive therapies, membranous nephropathy often progresses to end-stage kidney disease (ESKD). The objective of this prespecified analysis was to asse
Externí odkaz:
https://doaj.org/article/f7c6397ab9254160bd340782cae6b634
Publikováno v:
Glomerular Diseases, Vol 4, Iss 1, Pp 33-42 (2024)
Introduction: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and its subtypes, granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic GPA (EGPA), frequently present with acute kidney injury an
Externí odkaz:
https://doaj.org/article/ae92b63cd05349cd87131c4bc8871fe0
Autor:
Jingbo Niu, Omar Rosales, Abiodun Oluyomi, Susie Q. Lew, Wolfgang C. Winkelmayer, Glenn M. Chertow, Kevin F. Erickson
Publikováno v:
Kidney Medicine, Vol 6, Iss 4, Pp 100798- (2024)
Rationale & Objective: Because of coronavirus disease 2019 (COVID-19), the US government issued emergency waivers in March 2020 that removed regulatory barriers around the use of telemedicine. For the first time, nephrologists were reimbursed for tel
Externí odkaz:
https://doaj.org/article/73ca29ae98ff4dbe96fd1666dd71b456
Autor:
Joan Perelló, Joan Alberti, Juan Vicente Torres, Miguel D. Ferrer, M. Mar Perez, Firas Bassissi, Alex Gold, Paolo Raggi, Glenn M. Chertow, Carolina Salcedo
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background: Patients receiving dialysis have high cardiovascular risk in part due to extensive vascular calcification. In the CaLIPSO study, infusion of hexasodium fytate (SNF472), the hexasodium salt of inositol hexaphosphate, for 52 weeks thrice we
Externí odkaz:
https://doaj.org/article/7ccee23001fc4160a0848c9318babc57